摘要
间充质干细胞是一种具有自我更新和多向分化潜能的成体干细胞。大量的临床前试验显示其有望用于治疗以高病死率著称的ARDS，而相关临床研究却仍处于起步阶段。本文主要对近年来间充质干细胞治疗ARDS的临床研究进展进行综述。
As a type of somatic stem cell, mesenchymal stem cell is characterized by self-renewal and multilineage differentiation potential. Numerous preclinical trials have shown the promising therapeutic effect of mesenchymal stem cell on acute respiratory distress syndrome, but related clinical trials are still in the infancy. Herein, we review the clinical research advances on application of mesenchymal stem cell in treatment of acute respiratory distress syndrome in recent years.
出处
《国际呼吸杂志》
2017年第11期873-876,共4页
International Journal of Respiration
基金
国家自然科学基金（81670066）
广东省省级科技计划项目（2016A020216009）
关键词
间充质干细胞
急性呼吸窘迫综合征
临床研究
Mesenchymal stem cell
Acute respiratory distress syndrome
Clinical trial
